We are live on
!
Find out more
SONN
Sonnet BioTherapeutics
SONN
SONN
Delisted
SONN was delisted on the 2nd of December, 2025.
hedge funds and large institutions have $313K invested in Sonnet BioTherapeutics in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
10% less capital invested
Capital invested by funds: $348K → $313K (-$35K)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$33K |
| 2 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$23K |
| 3 |
CDH
Charles D. Hyman
|
-$16K |
| 4 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$11K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$8K |
